Navigation Links
Alfred Taubman Announces New $22M Gift to U-M

Surprise announcement of planned bequest comes at stem cell symposium

ANN ARBOR, Mich., Oct. 7 /PRNewswire-USNewswire/ -- Just over one year ago, retail pioneer A. Alfred Taubman announced a $22 million gift to the University of Michigan, to endow a new research institute aimed at understanding, treating and preventing human disease.

Today, at the institute's first symposium, he did it again -- announcing that he will bequeath an additional $22 million to the University for the institute's endowment.

The surprise announcement came during a symposium on stem cells, the first major event held by the A. Alfred Taubman Medical Research Institute.

"Over the past year, I've been impressed by the energy and ingenuity that the institute's scientific teams have displayed," says Mr. Taubman. "I hope this additional gift will ensure that this type of highly promising activity continues for decades to come at U-M."

Although the new gift is a bequest, it will eventually join the institute's existing endowment to help fund the research of future Taubman Scholars. Each scholar will be a top U-M scientist selected from the U-M Medical School faculty, with new ones selected at regular intervals.

The first five Taubman Scholars, including Taubman Institute director Eva Feldman, M.D., Ph.D., were named at the time of the institute's founding. Each was selected for his or her remarkable creativity and research that holds the potential to significantly advance the development of a cure or preventive treatment for a human disease.

"We're tremendously grateful for this visionary support, which will make possible the type of research that can only be done when scientists and their teams have true freedom to explore the most promising avenues and pursue the most tantalizing leads," says Robert Kelch, M.D., U-M executive vice president for medical affairs.

"Al Taubman's generosity and commitment to the University allow us to deepen our commitment to improve the health and well-being of society. His faith in our research provides the difference that separates the University of Michigan from other institutions," says U-M President Mary Sue Coleman.

Currently, the five Taubman Scholars are receiving $200,000 per year for three years, for their laboratory teams to use in the pursuit of new knowledge. The scholars also serve as advocates for research, by taking part in U-M efforts to educate the public about the importance of biomedical research, and of public and private support for such research. Today's stem cell symposium is among those efforts.

"In today's climate of uncertain federal funding for science, especially for high-risk, high-reward research, it's truly gratifying to have a donor like Al Taubman who understands the need and has both the foresight and means to fill that need," says U-M Medical School dean James O. Woolliscroft, M.D.

Mr. Taubman, who attended U-M, has been one of the institution's most generous supporters, with lifetime giving of more than $60 million before today's bequest announcement. More than $56 million of that amount has been given as part of the University's $2.5 billion Michigan Difference campaign, which concludes in November.

SOURCE University of Michigan Health System
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared ... traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... ... Dental professionals who would like to become more proficient on their knowledge of ... Advanced Implant Mentoring (AIM) CE course. Courses will be held on December 3rd, 4th ... Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to announce that individuals ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... North Carolina , 26 november 2015 ... Inc. (AAIPharma/CML) kondigt de geplande investering aan ... uitbreiding van de laboratoria en het mondiale ... . De uitbreiding zal resulteren in extra ... wordt voldaan aan de groeiende behoeften van ...
(Date:11/26/2015)... 26, 2015 --> ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... found that immunotherapy can be efficiently combined with photodynamic ...
Breaking Medicine Technology: